Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

First RayStation® Order in the United Kingdom

Published: Saturday, February 01, 2014
Last Updated: Saturday, February 01, 2014
Bookmark and Share
Ninewells to be the first clinical installation of RayStation® in the United Kingdom.

RaySearch Laboratories AB (publ.) has been awarded a contract to supply its RayStation® treatment planning system (TPS) to Tayside Cancer Centre, Ninewells Hospital & Medical School in Dundee, UK.

Ninewells Hospital & Medical School is one of the largest teaching hospitals in Europe. It has a comprehensive regional cancer centre serving the Tayside region of Scotland. The centre offers all forms of cancer therapy and treats approximately 1400 new cancer patients annually.

The radiotherapy department at Ninewells will replace its current TPS with RayStation®, as its treatment planning system for conventional 3D-CRT treatments, as well as more advanced treatments, such as IMRT and VMAT.

The order includes sophisticated solutions, such as multi-criteria optimization, enabling a more efficient treatment planning process. Multi-criteria optimization is a highly intuitive tool that lets the clinician evaluate the impact of changing different treatment priorities in real-time, which has a large potential to speed up the time-consuming plan optimization process.

The radiotherapy department at Ninewells Hospital will also implement dose tracking and adaptive planning using the dedicated tools available in RayStation, as well as investigating biological optimization and evaluation.

“NHS Tayside made the decision to purchase RayStation® following a comprehensive NHS Scotland procurement and evaluation process. The process took into consideration TPS generic specifications, site specific requirements by Tayside Cancer Centre and the benefits the system will bring to the centre over and above the competing systems. We look forward to working with the RaySearch team to produce the best possible treatment plans for patients”, says Salam Souliman, Head of RT Physics at Ninewells Hospital.

“The UK is a highly important market for us. We established our UK sales and service office in the second half of 2013 and this has already resulted in the first customer order. Ninewells is an excellent clinic and we are of course thrilled that they have now become our first UK customer”, says Johan Löf CEO of RaySearch.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Accuray and RaySearch Announce Long-Term Collaboration Agreement
Agreement will allow Accuray to co-market and offer the RayCare® oncology information system.
Tuesday, July 14, 2015
FDA Clears RaySearch 4.5
New version will help cancer centers improve their treatment planning process.
Wednesday, October 29, 2014
RaySearch Starts a New Collaboration with CNAO Foundation
Company has received an order for RayStation® from CNAO Foundation.
Thursday, December 26, 2013
Scientific News
Big Genetics in BC: The American Society for Human Genetics 2016 Meeting
Themes at this year's meeting ranged from the verification, validation, and sharing of data, to the translation of laboratory findings into actionable clinical results.
Genetics Control Regenerative Properties Of Stem Cells
Researchers define how genetic factors control regenerative properties of blood-forming stem cells.
Diabetes Missing Link Discovered
Researchers from the University of Auckland have shown that beta catenin plays a vital role in the control of insulin release from the pancreas.
Study Reveals New Role for Hippo Pathway in Suppressing Cancer Immunity
Hippo pathway signaling regulates organ size by moderating cell growth, apoptosis and stem cell renewal, but dysregulation contributes to cancer development.
Gene-Editing Improves Vision in Blind Rats
Scientists developed a targeted gene-replacement technique that can modify genes in both dividing and non-dividing cells in living animals.
Gene Editing Yields Tomatoes That Ripen Weeks Earlier
Research team develop method to make tomato plants flower and ripen fruit two weeks faster than current growth rates.
Exploring the Genome of the River Blindness Parasite
Researchers have decoded the genome of the parasite that causes the skin and eye infection known as river blindness.
Gene Therapy Maintains Clotting Factor for Hemophilia Patients
Following a single gene therapy dose, the highest levels of an essential blood clotting factor IX were observed in hemophilia B patients.
Unexpected Role for Epigenetic Enzymes in Cancer
Researchers use epigenetics to identify the role of an enzyme family as regulators of genetic message interpretation in yeast.
Genetic Links to Brain Cancer Cell Growth
Researchers discover clues to tumour behaviour from genetic differences between brain cancer cells and normal tissue cells.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!